Pan-cancer landscape of epigenetic factor expression predicts tumor outcome

被引:7
|
作者
Cheng, Michael W. [1 ]
Mitra, Mithun [2 ,3 ]
Coller, Hilary A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA
关键词
DNA METHYLATION; CHROMATIN; EPIGENOME; ENVIRONMENT; MECHANISMS; REGULATORS; HALLMARKS; PATTERNS; GENETICS; THERAPY;
D O I
10.1038/s42003-023-05459-w
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oncogenic pathways that drive cancer progression reflect both genetic changes and epigenetic regulation. Here we stratified primary tumors from each of 24 TCGA adult cancer types based on the gene expression patterns of epigenetic factors (epifactors). The tumors for five cancer types (ACC, KIRC, LGG, LIHC, and LUAD) separated into two robust clusters that were better than grade or epithelial-to-mesenchymal transition in predicting clinical outcomes. The majority of epifactors that drove the clustering were also individually prognostic. A pan-cancer machine learning model deploying epifactor expression data for these five cancer types successfully separated the patients into poor and better outcome groups. Single-cell analysis of adult and pediatric tumors revealed that expression patterns associated with poor or worse outcomes were present in individual cells within tumors. Our study provides an epigenetic map of cancer types and lays a foundation for discovering pan-cancer targetable epifactors. A pan-cancer machine learning model using epifactor expression data for five cancer types and single-cell analysis of adult and pediatric tumors reveal expression patterns associated with poor or worse outcomes are present in individual cells within tumors.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Pan-Cancer Biomarkers Changing the Landscape of Molecular Testing
    Yao, Jinjuan
    Arcila, Maria E.
    Ladanyi, Marc
    Hechtman, Jaclyn F.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 692 - 698
  • [22] A pan-cancer metabolic atlas of the tumor microenvironment
    Rohatgi, Neha
    Ghoshdastider, Umesh
    Baruah, Probhonjon
    Kulshrestha, Tanmay
    Skanderup, Anders Jacobsen
    CELL REPORTS, 2022, 39 (06):
  • [23] Accurate pan-cancer tumor purity estimation from gene expression data
    Revkov, Egor
    Sung, Ken W. -K.
    Skanderup, Anders J.
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Pan-cancer proteogenomics characterization of tumor immunity
    Petralia, Francesca
    Ma, Weiping
    Yaron, Tomer M.
    Caruso, Francesca Pia
    Tignor, Nicole
    Wang, Joshua M.
    Charytonowicz, Daniel
    Johnson, Jared L.
    Huntsman, Emily M.
    Marino, Giacomo B.
    Calinawan, Anna
    Evangelista, John Erol
    Selvan, Myvizhi Esai
    Chowdhury, Shrabanti
    Rykunov, Dmitry
    Krek, Azra
    Song, Xiaoyu
    Turhan, Berk
    Christianson, Karen E.
    Lewis, David A.
    Deng, Eden Z.
    Clarke, Daniel J. B.
    Whiteaker, Jeffrey R.
    Kennedy, Jacob J.
    Zhao, Lei
    Segura, Rossana Lazcano
    Batra, Harsh
    Raso, Maria Gabriela
    Parra, Edwin Roger
    Soundararajan, Rama
    Tang, Ximing
    Li, Yize
    Yi, Xinpei
    Satpathy, Shankha
    Wang, Ying
    Wiznerowicz, Maciej
    Gonzalez-Robles, Tania J.
    Iavarone, Antonio
    Gosline, Sara J. C.
    Reva, Boris
    Robles, Ana I.
    Nesvizhskii, Alexey I.
    Mani, D. R.
    Gillette, Michael A.
    Klein, Robert J.
    Cieslik, Marcin
    Zhang, Bing
    Paulovich, Amanda G.
    Sebra, Robert
    Guemues, Zeynep H.
    CELL, 2024, 187 (05) : 1255 - 1277.e27
  • [25] Pan-cancer metabolic profiling of the tumor microenvironment
    Rohatgi, Neha
    Ghoshdastider, Umesh
    Baruah, Probhonjon
    Skanderup, Anders Jacobsen
    CANCER RESEARCH, 2020, 80 (23)
  • [26] Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway
    Li, J.
    Huang, K. L.
    Zhang, T.
    Li, H.
    Zhao, J.
    Wang, H.
    NEOPLASMA, 2016, 63 (02) : 208 - 214
  • [27] The pan-cancer noninvasive screening and early detection by epigenetic techniques
    Yang, Yong
    Qin, Yang
    Zeng, Zhen
    Lu, Yinying
    Gong, Yuan
    Li, Yuemin
    Song, Lele
    EPIGENOMICS, 2021, 13 (09) : 649 - 652
  • [28] Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
    Liu, Yunqiang
    Tu, Mengjun
    Wang, Lingling
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 2171 - 2185
  • [29] Integrative epigenetic and genetic pan-cancer somatic alteration portraits
    Salas, Lucas A.
    Johnson, Kevin C.
    Koestler, Devin C.
    O'Sullivan, Dylan E.
    Christensen, Brock C.
    EPIGENETICS, 2017, 12 (07) : 561 - 574
  • [30] The pan-cancer, pan-biomarker landscape for precision immuno-oncology.
    McLeod, Howard L.
    Berglund, Anders E.
    Yao, Jiqiang
    Avedon, Melissa
    Teer, Jamie K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)